share_log

Evercore ISI Group Maintains Outperform on Cabaletta Bio, Lowers Price Target to $15

Benzinga ·  Aug 12 09:57  · Ratings

Evercore ISI Group analyst Gavin Clark-Gartner maintains Cabaletta Bio (NASDAQ:CABA) with a Outperform and lowers the price target from $25 to $15.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment